Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 70-90 kDa, reducing conditions. MW (theoretical): 61.7 kDa (monomer). The Recombinant Human KIR3DL1 Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human KIR3DL1 Fc Chimera Protein has been validated for the following applications: Binding Activity.
Size
50 ug
Concentration
n/a
Applications
Binding Activity
Other Names
AMB11, CD158 antigen-like family member E, CD158E, CD158e antigen, CD158e1, CD158e1/2, CD158e2, cl-11, cl-2, HLA-BW4-specific inhibitory NK cell receptor, killer cell immunoglobulin-like receptor 3DL1, killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail1,nkat3, killer Ig receptor, KIR antigen 3DL1, KIR3DL1/S1, KIR3DS1, MGC119726, MGC119728, MGC126589, MGC126591, MHC class I NK cell receptor, Natural killer-associated transcript 3, Nkat3, NKAT-3, NKAT3KIR, NKB1, NKB1B, NKB1CD158E1, NK-receptor, p70 killer cell inhibitory receptor, p70 natural killer cell receptor clones CL-2/CL-11, p70 NK receptor CL-2/CL-11